Search: 

Request for proposals (RFPs)

Advance Market Commitments (AMC) Baseline Study - RFP

Advance Market Commitments (AMCs) are a new approach to public health funding designed to stimulate the development and manufacture of vaccines for developing countries. Donors commit money to guarantee the price of vaccines once they have been developed, thus creating the potential for a viable future market. Decisions about which diseases to target, criteria for effectiveness, price and long-term availability are made in advance by an independent advisory group. The donor commitments provide vaccine makers with the incentive they need to invest the considerable sums required to conduct research, train staff and build manufacturing facilities.

The GAVI Fund (GAVI) would like to invite you to participate in a RFP (RFP-0006-08) . The goal of this RFP is to find a contractor who can perform an Advance Market Commitments (AMC) Baseline Study by collecting annual data from 2005-2008 at both the industry and country level. The data collected will then be used to develop and simulate two counterfactual for GAVI’s AMC Initiative. The key findings from this study will serve to establish the vaccine environment prior to the AMC, as well as through the counterfactuals, help measure the impact of GAVI’s AMC initiative since its inception.

Interested parties are required to provide an intent to participate confirmation by August 12, 2008.

The RFP proposal is due on August 30, 2008.

Download

Accelerated Vaccine Introduction (AVI) activities - RFP

The GAVI Alliance and The GAVI Foundation would like to announce the release of a Request for Proposals (RFP). The goal of this RFP is to find an organisation or consortium of partners that can conduct activities to accelerate the introduction of rotavirus, pneumococcal and potentially other new vaccines into GAVI eligible countries, through the Accelerated Vaccine Introduction initiative (AVI). The AVI is an umbrella of support activities at the global, regional and country level to provide assistance to countries in making decisions on the introduction of these and potentially other new vaccines.

Download